Weight management and sugar level control have emerged as significant health issues across the globe. However, many individuals are facing the problems of obesity and type 2 diabetes even after observing proper diet and exercising. Here is where the role of today’s medicines like Semaglutide is gaining popularity.
What Is Semaglutide?
This medicine is prescription based normally used in the management of type 2 diabetes as well as weight loss. It is classified as one of the GLP-1 agonists drugs which functions as an analogue of the natural hormone that controls blood glucose levels and appetite. It is available in the form of injections as well as oral tablets.
How Does The Medicine Work?
The active mechanism of the medicine as it functions by working like a hormone naturally produced in the body known as GLP-1 (glucagon-like peptide-1). The medication helps in maintaining blood sugar levels by promoting the secretion of insulin when there is too much blood sugar and decreasing glucose output from the liver. Additionally, it slows down the rate of food digestion, thus making patients feel fuller for long periods. This ensures proper appetite suppression and food craving reduction.
Key Benefits of The Medicine?
1. Effective Glucose Management
It assists in keeping a constant level of blood sugar, minimizing the risks of any health problems associated with diabetes.
2. Helps in Losing Weight
The main benefit of this medication is that it allows lowering appetite and results in losing weight.
3. Helps Avoid Cardiovascular Issues
Some research proves that this medicine decreases the chances of developing heart attack and stroke in patients with type 2 diabetes.
4. Enhances Metabolic Health
It promotes good insulin activity and improves cholesterol in the future.
What Are The Possible Side Effects?
Even though semaglutide is effective for blood sugar control and weight management, however some patient’s may experience temporary or manageable side effects such as:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Loss of appetite
- Pancreatitis
- Gallbladder problems
- Kidney issues
- Allergic reactions
Who Can Benefit from Semaglutide?
The medicine can be used by:
- Adults suffering from type 2 diabetes.
- Individuals having obesity or being overweight.
- Patients not showing improvement through diet and exercises.
- People at the risk of developing cardiovascular diseases.
However, it should not be used by:
- Pregnant or nursing mothers as this may harm the developing baby.
- People having a history of specific types of thyroid cancer.
- Individuals with serious gastrointestinal problems.
Conclusion
The medication semaglutide has become an excellent treatment choice for type 2 diabetes and obesity management. It helps by affecting the functions of appetite, insulin, and glucose in the body. However, it requires professional advice for its use to be safe and effective.
FAQs
1. Does medicine necessitate changes in lifestyle?
Yes, for maximum effectiveness, Semaglutide should be used along with proper dietary and exercise programs. Semaglutide works better when it is coupled with some lifestyle changes. It does not substitute proper lifestyles.
2. Is Semaglutide a lifelong therapy?
It can be a lifetime therapy depending on the individual patient’s conditions. Stopping its use abruptly might result in weight gain or poor control of blood glucose levels. Consult with your doctor first.
References
- Knudsen, L. B., & Lau, J. (2019). The discovery and development of liraglutide and semaglutide. Frontiers in endocrinology, 10, 155.https://pubmed.ncbi.nlm.nih.gov/31031702/
- Ryan, D. H. (2021). Next generation antiobesity medications: setmelanotide, semaglutide, tirzepatide and bimagrumab: what do they mean for clinical practice?. Journal of obesity & metabolic syndrome, 30(3), 196. https://pubmed.ncbi.nlm.nih.gov/34518444/
- Goldenberg, R. M., & Steen, O. (2019). Semaglutide: review and place in therapy for adults with type 2 diabetes. Canadian journal of diabetes, 43(2), 136-145. https://www.sciencedirect.com/science/article/pii/S1499267118301096
- Andreadis, P., Karagiannis, T., Malandris, K., Avgerinos, I., Liakos, A., Manolopoulos, A., … & Tsapas, A. (2018). Semaglutide for type 2 diabetes mellitus: a systematic review and meta‐analysis. Diabetes, Obesity and Metabolism, 20(9), 2255-2263. https://pubmed.ncbi.nlm.nih.gov/29756388/
- Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2023). Semaglutide for the treatment of obesity. Trends in cardiovascular medicine, 33(3), 159-166.https://www.sciencedirect.com/science/article/abs/pii/S1050173821001584
